The Relationship Between the Dietary Inflammatory Index (DII®) and Incident Depressive Symptoms: A Longitudinal Cohort Study by Shivappa, Nitin et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.jad.2018.04.014
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Shivappa, N., Hébert, J. R., Veronese, N., Caruso, M. G., Notarnicola, M., Maggi, S., ... Solmi, M. (2018). The
Relationship Between the Dietary Inflammatory Index (DII®) and Incident Depressive Symptoms: A Longitudinal
Cohort Study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.04.014
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
 Accepted Manuscript
The Relationship Between the Dietary Inflammatory Index (DII
R©
) and
Incident Depressive Symptoms: A Longitudinal Cohort Study
Nitin Shivappa , James R. He´bert , Nicola Veronese ,
Maria Gabriella Caruso , Maria Notarnicola , Stefania Maggi ,
Brendon Stubbs , Joseph Firth , Michele Fornaro , Marco Solmi
PII: S0165-0327(17)32592-2
DOI: 10.1016/j.jad.2018.04.014
Reference: JAD 9668
To appear in: Journal of Affective Disorders
Received date: 14 December 2017
Revised date: 18 February 2018
Accepted date: 2 April 2018
Please cite this article as: Nitin Shivappa , James R. He´bert , Nicola Veronese ,
Maria Gabriella Caruso , Maria Notarnicola , Stefania Maggi , Brendon Stubbs , Joseph Firth ,
Michele Fornaro , Marco Solmi , The Relationship Between the Dietary Inflammatory Index (DII
R©
) and
Incident Depressive Symptoms: A Longitudinal Cohort Study, Journal of Affective Disorders (2018),
doi: 10.1016/j.jad.2018.04.014
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service
to our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and
all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
1 
 
Highlights 
 Dietary inflammatory index (DII®) is a validated measure of inflammatory potential of 
the diet. 
 Highest DII® quartile is associated with incident depressive symptoms as defined by 
CES-D score ⩾16 after a follow-up of 8 years in subjects at risk of arthritis (HR: 1.24; 
95% CI: 1.01-1.52; p=0.04). 
 Analyses were adjusted for 10 potential confounders at baseline, included age, BMI, 
baseline CES-d score. 
 This is the first longitudinal study assessing the association between DII® and 
depressive symptoms in an American population. 
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Running title: DIETARY INFLAMMATORY INDEX (DII
®) 
AND INCIDENT DEPRESSIVE 
SYMPTOMS 
ABSTRACT 
Background 
Diet is a common source of inflammation, and inflammation is associated with depression.  We 
examined the association between the dietary inflammatory index (DII
®
), a validated measure of 
inflammatory potential of the diet, and risk of depression in a cohort of older North American 
adults.  
 
Methods 
This longitudinal study, with a follow-up of 8 years, included 3,648 participants(1,577 males, 2,071 
females; mean age: 60.6 years) with/at risk of knee osteoarthritis.   DII
®
 scores were calculated 
using the validated Block Brief 2000 Food-Frequency Questionnaire. Center for Epidemiological 
Studies Depression-20 scale was used to define depressive symptoms. The relationship between 
baseline DII
®
 score and incident depression was assessed through Cox‟s regression analysis, 
adjusted for potential confounders, and reported as hazard ratios (HRs).  
Results 
In total, 837 individuals (310 men and 527 women) developed incident depressive symptoms over 
the course of 8 years. Participants in the most pro-inflammatory group (quartile 4) had 
approximately 24% higher risk of developing depressive symptoms compared to subjects with the 
most anti-inflammatory diet (HR: 1.24; 95% CI: 1.01-1.53; p=0.04).  
Conclusion 
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These results suggest that a pro-inflammatory diet may be associated with higher incidence of 
depressive symptoms in a cohort of older Americans. Transitioning to a more anti-inflammatory 
diet may reduce depression risk.  
 
Keywords: depression, health behavior, neuroimmunology, old age 
INTRODUCTION 
Depression is a chronic condition with an estimated lifetime prevalence of 14.6% and 11.1% in 
high- and lower-and-middle-income countries, respectively. (Bromet et al., 2011; Kessler and 
Bromet, 2013).  Moreover, it is estimated that depression is one of the leading sources of disability 
worldwide (2015; Ferrari et al., 2013), being associated with reduced quality of life and medical 
morbidity (Ferrari et al., 2013; Kessler and Bromet, 2013; Rackley and Bostwick, 2012). Increasing 
evidence also shows that depression might confer a higher risk for several non-communicable 
diseases (e.g., diabetes (Rotella and Mannucci, 2013a), obesity (Luppino et al., 2010), metabolic 
syndrome(Vancampfort et al., 2015), cardiovascular disease (Correll et al., 2017), stroke (Tsilidis et 
al., 2015), acute myocardial infarction (Wu and Kling, 2016), dementia (Cherbuin and Kim, 2015) 
and physical health co-morbidities(Read et al., 2017)). At the same time, these chronic health 
conditions appear to increase the likelihood of developing depression(Bennett and Thomas, 2014; 
Hackett and Pickles, 2014; Lichtman et al., 2014; Luppino et al., 2010; Rotella and Mannucci, 
2013b) . 
There is now robust evidence to suggest that inflammation plays a pivotal role in the development 
of depression, and that people with confirmed depression have elevated levels of various 
inflammatory markers, including c-reactive protein, interlueking-6 and tumor necrosis factor 
(Kohler et al., 2017a; Kohler et al., 2017b) Increasing evidence has been accumulating linking diet 
to inflammation (Aeberli et al., 2011; Cavicchia et al., 2009). The Dietary Inflammatory Index 
(DII
®
)
 
is a literature-derived dietary tool, useful for assessing the overall inflammatory potential of 
individual‟s diet.(Shivappa et al., 2014a) Higher DII® values are strongly associated with serum 
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inflammatory markers, including IL-6, hs-C-Reactive Protein (CRP), fibrinogen, homocysteine and 
Tumor Necrosis Factor (TNF)-α(Ramallal et al., 2015; Shivappa et al., 2014b; Tabung et al., 2015b; 
Wirth, 2016; Wirth et al., 2014b), suggesting a close relationship between this index and bio-
humoral inflammatory parameters. The DII
®
 has also has been used to assessed the relationship 
between diet quality related to inflammation and several chronic inflammation-related outcomes, 
such as metabolic and respiratory diseases, frailty, cancer and fractures.(Orchard et al., 2016; 
Shivappa et al., 2017; Tabung et al., 2015a; Wirth et al., 2014a; Wood et al., 2015) Two cross-
sectional (Phillips et al., 2017; Wirth et al., 2017) and four longitudinal (Adjibade et al., 2017; 
Akbaraly et al., 2016; Sanchez-Villegas et al., 2015; Shivappa et al., 2016) studies have investigated 
the association between DII
®
 scores and depression, showing consistent data supporting such an 
association from both cross-sectional and longitudinal data. DII
®
 has not been associated with 
incident depression or depressive symptoms in a prospective study in American population. 
Given this background, we aimed to investigate if higher DII
®
 scores were associated with a higher 
risk of depressive symptoms during follow-up period (assessed through CES-d score ⩾16) in a 
large cohort of American people at high risk of osteoarthritis (OA), over 8 years of follow-up.  
 
MATERIALS AND METHODS 
Data source and subjects 
Data were included from the Osteoarthritis Initiative (OAI) database. The OAI is freely available 
(http://www.oai.ucsf.edu/). Within the OAI, potential participants were recruited across four clinical 
sites in the United States of America (Baltimore, MD; Pittsburgh, PA; Pawtucket, RI; and 
Columbus, OH) between February 2004 and May 2006. In this database, we identified people who 
either: (1) had knee OA with knee pain for a 30-day period in the past 12 months or (2) were at high 
risk of developing knee OA (Eby and Eby, 2006) with data collected during baseline and screening 
evaluations in November 2008. Exclusion criteria for the OAI were: (1) Rheumatoid Arthritis (RA) 
or inflammatory arthritis; (2) unlikely to demonstrate measurable loss of joint space during the 
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study; (3) bilateral total knee joint replacement or plans to have bilateral knee replacement in the 
next 3 years; (4) unable to undergo a 3.0 Tesla MRI exam of the knee because of contraindications 
or inability to fit in the scanner or in the knee coil; (5) positive pregnancy test; (6) unable to provide 
a blood sample for any reason; (7) use of ambulatory aids other than a single straight cane; (8) co-
morbid conditions that might  interfere with the ability to participate in a 4-year study; (9) unlikely 
to reside in the clinic area for at least 3 years; (10) current participation in a double-blind 
randomized controlled trial; or (11) unwilling to sign informed consent.  
All participants provided informed written consent. The OAI study was given full ethical approval 
by the institutional review board of the OAI Coordinating Center, at the University of California in 
San Francisco. 
 
Dietary data and Dietary inflammatory index (exposure) 
Dietary intake was assessed using a validated tool, the Block Brief 2000 Food Frequency 
Questionnaire (FFQ) during the baseline visit. (Block et al., 1990). Seventy items were assessed to 
determine an individual‟s typical food and beverage consumption over the past year. The frequency 
of consumption was reported at nine levels of intake from “never” to “every day”. In addition, 
seven dietary behavior questions were asked regarding food preparation methods and fat intake, one 
question on fiber intake, and 13 questions on vitamin and mineral intakes. 
 
The details of development of DII
®
 is described by Shivappa et al. elsewhere (Shivappa et al., 
2014a) . High sensitivity CRP measurements were used to examine construct validity of the DII
®
 in 
a longitudinal cohort using multiple (up to 15) 24-hour dietary recall interviews and up to five 7-day 
dietary recalls.  The DII
®
 was subsequently validated in four studies among different populations 
with a variety of inflammatory biomarkers (i.e., interleukin, IL-6, hs-CRP, fibrinogen, 
homocysteine and TNF-α) (Ramallal et al., 2015; Shivappa et al., 2014b; Tabung et al., 2015b; 
Wirth, 2016; Wirth et al., 2014b). In this updated version of the DII
®
, 1943 articles were reviewed 
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and scored. Forty-five food parameters, including foods, nutrients, and other bioactive compounds, 
were identified based on their inflammatory effect on six specific inflammatory markers, including 
CRP, IL-1β, IL-4, IL-6, IL-10 and tumor necrosis factor (TNF)-α. A regionally representative world 
database representing diet surveys from 11 countries was used as a comparative standard for each of 
the 45 parameters (i.e. foods, nutrients, and other food components).  Intake values from this 
database were used to calculate the DII
®
 scores. This is explained in more detail in the DII
®
 
Methods paper (Shivappa et al., 2014a). Briefly, a standard mean for each parameter from the 
representative world database was subtracted from the actual individual exposure and divided by its 
standard deviation to generate Z scores. These Z scores were converted to percentile ranks (thus 
minimizing effects of outliers/right- skewing).  These values were then doubled and 1 was 
subtracted to achieve symmetrical distribution with values centered on 0. The resulting value was 
then multiplied by the corresponding inflammatory score for each food parameter and summed 
across all food parameters, to obtain the overall DII
® 
score. Using the FFQ, we calculated the DII
®
 
based on energy-adjusted intake of the 24 single food  parameters of the 45 possible food 
parameters that were available from the FFQ using the energy density approach, which calculated 
the DII
®
 per 4184 kJ (1000 kcal) of energy (Willett et al., 1997). The 24 food parameters available 
for DII
®
 calculation in this study were vitamin B12, vitamin B6, β-carotene, carbohydrate, 
cholesterol, fat, fibre, folic acid, iron, magnesium, monounsaturated fat acids (MUFA), niacin, 
protein, polyunsaturated fatty acids (PUFA), riboflavin, saturated fat acids(SFA), selenium, thiamin, 
vitamin A, vitamin C, vitamin E, vitamin D, zinc, and caffeine.  
 
Outcome 
The presence of depressive symptoms was derived from the 20-item Center for Epidemiologic 
Studies-Depression (CES-D) instrument (Radloff, 1977). The range of possible values for this 
scores is 0 to 60, where higher scores indicate more depressive symptoms. (Radloff, 1977) A cut-off 
of 16 was used for the diagnosis of incident depressive symptoms.(Veronese et al., 2016) 
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Covariates 
Eleven covariates (other than baseline CES-D) were identified a priori as potential confounding 
factors. These included: age; sex; body mass index (BMI); physical activity evaluated using the 
total score for the Physical Activity Scale for the Elderly scale (PASE) (Washburn et al., 1999); 
race; smoking habit; educational attainment level (college or higher vs. others); yearly income (< or 
> $50,000 or missing data); statins use; NSAIDs or cortisone use; and a validated general health 
measure of self-reported comorbidities assessed through the modified Charlson Comorbidity Index 
score.(Katz et al., 1996) 
 
Statistical analyses 
Data on continuous variables were normally distributed according to the Kolmogorov-Smirnov test. 
Data were presented as means and standard deviation values (SD) for quantitative measures, and 
frequency and percentages for all discrete variables. Levene‟s test was used to test the 
homoscedasticity of variances and, if its assumption was violated, Welch‟s ANOVA was used. P-
values were calculated using the Jonckheere-Terpstra test (Jonckheere, 1954) for continuous 
variables and the Mantel-Haenszel Chi-square test for categorical variables.  
To assess the relationship between DII
®
 score and incident depressive symptoms, a Cox‟s 
regression analysis was conducted where the incident depressive symptoms were defined as the 
discrete „outcome,‟ time-to-event was the temporal factor, and the DII® score was the „exposure‟. 
The basic model was not adjusted for any confounders. The fully adjusted model included the 
following covariates: age (as continuous); sex; race (Whites vs. others); BMI (as continuous); 
education (≥college degree vs. others); smoking habits (current and previous vs. others); yearly 
income (categorized as > or < US$50,000 or missing data); Charlson Comorbidity Index; PASE 
score (as continuous); CES-D at baseline (as continuous); statins use (yes vs. no); NSAIDS or 
cortisone use (yes vs. no).  
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Multi-collinearity among covariates was assessed through variance inflation factor (VIF) (Miles, 
2009), taking a cut-off of 2 as the criterion for exclusion. No covariates met this criterion and 
therefore none was excluded for this reason. Adjusted hazard ratios (HR) and 95% confidence 
intervals (CI) were calculated to estimate the strength of the associations between DII
®
 score 
(reported as quartiles) and incident depressive symptoms. P values for trend were calculated across 
DII
®
 groups using the Wald test, based on a score derived from the median value of each baseline 
DII
®
 group. We finally modelled DII
®
 score as a continuous variable, reporting the association 
between increase in one SD as the exposure variable.  
A p<0.05 was deemed statistically significant.  All analyses were performed using SPSS
®
 software 
version 21.0 for Windows (SPSS Inc., Chicago, Illinois). 
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RESULTS 
Sample selection 
The OAI dataset initially included a total of 4,796 individuals. A total of 264 participants were 
excluded due to missing baseline data regarding CES-D and 462 were excluded for having 
depressive symptoms (i.e. CES-D >16) at baseline. In addition, we were not able to compute DII
®
 
scores for another 278 individuals (80 participants had too many missing data for us to compute a 
DII
®
 score, and another 198 participants reported consuming total energy outside of the protocol-
required acceptable range; i.e., less than 800/greater than 4200 Kcal for men and less than 
500/greater than 3800 for women). Thus, 3,608 participants were included in this study.  
Descriptive characteristics  
The cohort consisted of 2,037 females (56.5%). Mean age was 61.4 years (±9.2 years; range: 45-79 
years) and mean DII
®
 was -3.25 (±1.61 points; range: -5.54 to 3.57).  
Table 1 illustrates the baseline characteristics by DII
®
 quartiles in the sample as whole. Those in the 
highest DII
®
 quartile (reflecting the most pro-inflammatory diets) were significantly younger and 
more frequently males than participants with lower DII
®
 values (p for trend <0.0001). The 
participants with higher DII
®
 values at baseline were more frequently smokers (p for trend=0.001), 
less educated (p for trend=0.002), more frequently obese (p for trend <0.0001), and used less 
frequently statins (p for trend <0.0001).  
Finally, people with higher DII
®
 values reported significantly higher baseline values at CES-D (p 
for trend <0.0001) (Table 1).  
Dietary inflammatory index and incident depressive symptoms  
Over a mean follow-up of 8 years, 837 individuals (310 men and 527 women; = 23.2% of the 
baseline population) had depressive symptoms, for a global incidence of 39 (95%CI: 36-41) people 
for 1,000 persons-years. The incidence of depressive symptoms was significantly higher in people 
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having higher DII
®
 values at baseline (Q4: 45; 95%CI: 40-51 vs. Q1: 32; 95%CI: 28-37; p<0.0001) 
(Table 2).  
Cox‟s regression analysis, adjusting for 12 potential confounders at baseline, with the lowest DII® 
as reference (=Q1), showed that participants with the highest DII
®
 score (=Q4) had a significantly 
higher probability of incident depressive symptoms (HR: 1.24; 95% CI: 1.01-1.53; p=0.04; Table 2, 
figure 1). However, the p for trend did not reach the statistical significance (p=0.10). An increase in 
one SD of DII
®
 (=1.61 points) did not increase the risk of depressive symptoms at follow-up 
(adjusted HR=1.02; 95%CI: 0.96-1.09; p=0.52). 
In the multivariate analysis, other factors significantly associated with the onset of depressive 
symptoms during follow-up were: female sex (HR=1.23; 95%CI: 1.06-1.44; p=0.008), higher BMI 
(HR: 1.02; 95% CI: 1.006 to 1.04; p=0.007), and higher CES-D (HR: 1.19; 95% CI: 1.17 to 1.21; 
p<0.0001).  
We also conducted multiple post-hoc sensitivity analyses in order to evaluate the interaction 
between DII
®
 score and selected participant characteristics [i.e., age ≤65 years, overweight/obese 
(≥25kg/m2) vs. normal weight (18.5kg/m2<BMI ≥25kg/m2), yearly income, gender, race, education, 
smoking habits, yearly income, presence at baseline of knee OA] in the association with incident 
depressive symptoms, but none emerged as moderator of our findings (p>0.05 for the interaction for 
all factors).  
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DISCUSSION 
In this longitudinal study, we found that a more pro-inflammatory diet intake (indicated by higher 
DII
®
 scores) was associated with greater incidence of depressive symptoms as defined by CES-D 
⩾16. During a follow-up period of 8 years, after adjusting for several potential confounders at 
baseline, individuals with the highest DII
®
 score (i.e. having a more pro-inflammatory diet) had a 
24% higher risk of depressive symptoms (p=0.04) compared with those with the lowest DII
®
 score. 
At baseline, people with higher DII
®
 scores, already had a higher prevalence of known risk factors 
for depression during follow-up such as lower education (Bjelland et al., 2008), obesity (Luppino et 
al., 2010), and higher CES-D values. However, all our analyses are adjusted for these confounders 
and the results remain still significant. Our findings agree with those already present in literature. In 
a cohort study of 15,093 university graduates, participants in the highest quintile of DII
®
 reported a 
significant higher risk of depression of about 50%. (Sanchez-Villegas et al., 2015) A substantial 
similar finding emerged from another study involving a total of 6,438 women with a mean age of 
52.0 years at baseline, followed-up over 12 years (Shivappa et al., 2016). However, it is of interest 
that a more recent study failed to find any significant association between baseline DII
®
 values and 
incident depressive symptoms in 3,523 young participants followed-up for 12.5 years(Adjibade et 
al., 2017), indicating that other studies are needed to better highlight the association between DII
®
 
and depression. Altogether these findings probably indicate that the DII
®
 is a better predictor of 
depression and depressive symptoms in older than younger people, probably because older people 
have had greater cumulative exposure to DII
®
 than younger subjects during their lives. However, 
further research is needed to confirm this association.  
It is widely known that inflammation is associated with depression. In the early 1990‟s, the 
macrophage theory for depression was first hypothesized (Smith, 1991), particularly when these 
cells are activated by any damage (M1 cells). Increasing evidence showing a role of M1 cells 
(including microglial cells and central nervous system macrophages) in depression has accumulated 
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(Yirmiya et al., 2015), because the peripheral M1 cells could be a main source of elevated cytokines 
in depression.(Wohleb et al., 2016) Moreover, other evidences reported that subsets of patients with 
depression have an altered peripheral immune system, with impaired cellular immunity and 
increased levels of proinflammatory cytokines, such as cytokines might influence neurotransmitter 
metabolism, neuroendocrine function and regional brain activity and all these factors may be 
relevant for the onset of depression (Wohleb et al., 2016; Zunszain et al., 2013).  However, it should 
be noted that in the studies that adjusted their analyses for serum levels of cytokines, DII
®
 remains 
significantly associated with the onset of depression.(Sanchez-Villegas et al., 2015; Shivappa et al., 
2016) These findings probably suggest that unhealthy (pro-inflammatory) diet independently 
contributed to the onset of depression, consequently resulting in important clinical consequences. 
Diet seems to be an  important target for the prevention of depression.(Sanchez-Villegas and 
Martínez-González, 2013) Some observational studies reported that healthy diets (such as 
Mediterranean one) are associated with a lower incidence of depression in adults. (Sanchez-Villegas 
and Martínez-González, 2013) Our study further reinforces these findings suggesting that healthy 
diets are probably necessary for the prevention of depression. Indeed, a recent RCT(Jacka et al., 
2017) in adults experiencing depressive symptoms showed that adoption of the Mediterranean diet 
significantly reduced depressive symptoms. Moreover, a synergic anti-inflammatory action may be 
hypothesized, between antidepressants (Kohler et al., 2017b), and Mediterranean or macrobiotic 
diet, opening the field to potential preventive interventions, or early interventions that could target 
inflammatory pathways before or when minimal symptoms have presented. In addition, the gut-
brain-axis may play a role in depression onset interacting with pro-inflammatory diet, which may 
contribute to the leaky gut and increased bacterial translocation in depression itself, as well as in 
other diet-related conditions such as diabetes and obesity (Slyepchenko et al., 2016).. Well-designed 
and conducted RCTs targeting gut as a treatment target with probiotics for depression are definitely 
needed; and this should entail a shift from healthy populations to studies conducted in clinical 
populations (Ng et al., 2018). 
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Further interventional studies are, however, needed to confirm these findings, at least in subjects 
with evidence of pro-inflammatory state. Also, in addition to avoiding a pro-inflammatory diet, 
prevention and treatment of depression can not ignore healthy life style including regular physical 
exercise, and avoiding recreational drugs which in turn are associated with inflammation (Fuster et 
al., 2015; Ghazavi et al., 2013; Gonzalez-Reimers et al., 2014). 
The results of our research should be considered in light of its limitations. The principal 
shortcoming is that we used a definition of depressive symptoms based only on CES-D, without 
accounting for other aspects of depression or for the use of medications. This could introduce an 
important bias in our results. Second, the comorbid medical conditions assessed in this study were 
self-reported. Another limitation could be the non-availability of data on the remaining 21 food 
parameters of the DII
®
. Some components such as turmeric, saffron and eugenol are not consumed 
in high quantity in this population; so, non-availability of these food parameters may not have 
played major role in this association. However, inclusion of parameters such as flavonoids, which 
are commonly consumed, may influence the results. Third, in the OAI data on serum concentrations 
of inflammatory markers inflammatory parameters were not collected.  Therefore,  we cannot adjust 
for these potential confounders. Finally, the findings derived from the OAI are not fully 
generalizable to other populations because this database includes only people having, or at high risk 
of knee OA.  
In conclusion, higher DII
®
 scores were associated with a higher incidence of depressive symptoms, 
even after considering several potentially important confounders measured at baseline. Future 
randomized controlled trials with diets rich in anti-inflammatory compounds are needed to further 
confirm our findings.  
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FIGURE LEGEND 
Figure 1. Association between Dietary Inflammatory Index (expressed in quartiles) and 
incident depressive symptoms, adjusted for potential confounders.  
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Table 1. Characteristics of the participants classified according to their baseline dietary 
inflammatory index, Osteoarthritis Initiative (OAI), 2004-6.  
 
 
Q1 
(n=902) 
DII  
 Q2 
(n=902) 
DII 
Q2 
(n=902) 
DII 
Q4 
(n=902) 
DII 
p-value
 a
 
General characteristics      
Age (years) 63.2 (8.7) 62.2 (9.2) 61.1 (9.2) 58.9 (9.0) <0.0001 
Females (n, %) 638 (70.7) 562 (62.3) 463 (51.3) 374 (41.5) <0.0001 
PASE (points) 163 (79) 165 (83) 159 (82) 168 (82) 0.15 
White race (n, %) 748 (83.1) 756 (83.8) 774 (85.8) 718 (79.7) 0.14 
Smoking (previous/current) 
(n, %) 
388 (43.0) 406 (45.0) 
427 (47.3) 456 (50.6) 0.001 
Graduate degree (n, %) 323 (35.8) 311 (34.5) 286 (31.7) 267 (29.6) 0.002 
Yearly income (> $50,000) 331 (36.7) 321 (35.6) 290 (32.2) 328 (36.4) 0.53 
Medical conditions and 
medications 
  
   
BMI (Kg/m
2
) 27.3 (4.5) 28.2 (4.4) 28.9 (4.6) 29.8 (4.8) <0.0001 
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Table 2. Association between dietary inflammatory index and incidence 
of depressive symptoms, Osteoarthritis Initiative (OAI), 2004-6.  
.  
 
Incidence 
(* 1,000 persons-
years) 
(95%CI) 
Unadjusted 
HR 
(95%CI) 
P value 
Fully 
adjusted
a 
HR 
(95%CI) 
P value 
Q1 32 (28-37) 1 [reference] 1 [reference] 
Q2 
39 (34-45) 1.19 (0.97-
1.44) 
0.09 1.20 
(0.99-
1.47)1.21 
(0.99-
1.48) 
0.067 
Q3 
39 (34-44) 1.15 (0.94-
1.40) 
0.17 1.06 
(0.86-
1.3029) 
0.5861 
Q4 
45 (40-51) 1.32 (1.09-
1.60) 
0.005 1.24 
(1.01-
0.04 
 
